Intratumoral IL-17+ Cells and Neutrophils show Strong Prognostic Significance in Intrahepatic Cholangiocarcinoma
Fang-Ming Gu,Qiang Gao,Guo-Ming Shi,Xin Zhang,Jiping Wang,Jia-Hao Jiang,Xiao-Ying Wang,Ying-Hong Shi,Zhen-Bin Ding,Jia Fan,Jian Zhou
DOI: https://doi.org/10.1245/s10434-012-2268-8
IF: 4.339
2012-03-13
Annals of Surgical Oncology
Abstract:BackgroundInflammatory reactions at a tumor site have both detrimental and beneficial effects on tumor progression. This study was designed to assess the clinical significance of tumor-infiltrating inflammatory cells in patients with intrahepatic cholangiocarcinoma (ICC).MethodsA total of 123 consecutive ICC patients who underwent curative resection were enrolled. Tissue microarray and immunohistochemistry were used to analyze the distribution and clinical relevance of IL-17+, FOXP3+, CD8+, CD66b+ cells, and microvessel density (CD34) in different microanatomical areas.ResultsIL-17+ cells, FOXP3+ lymphocytes, CD66b+ neutrophils, and microvessels were enriched predominantly in intratumor (IT) area, whereas CD8+ lymphocytes were most abundant in tumor invasive front. On univariate analyses, increasing IL-17IT+ and neutrophilsIT were significantly associated with worse patient survival. Multivariate analyses revealed that IL-17IT+ (hazard ratio [HR] = 1.59; 95% confidence interval [CI], 1.05–2.41; P = 0.028), neutrophilsIT (HR = 1.76; 95% CI, 1.16–2.65; P = 0.007), and their combination (HR 2.8; 95% CI 1.72–4.57; P < 0.001) were independent prognostic factors, which were superior to conventional clinicopathologic features, such as intrahepatic metastasis and TNM stage. IL-17IT+ significantly correlated with the presence of lymph node metastasis, intrahepatic metastasis, and advanced stages, whereas neutrophilsIT correlated with the presence of vascular invasion. In addition, significant positive correlations were detected among densities of IL-17+ cells, neutrophils, and microvessel density.ConclusionsOur data suggested that intratumor IL-17+ cells, neutrophils are novel, powerful predictors of prognosis in patients with ICC.
oncology,surgery